Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial.
Accelerometric tremorgrams were recorded from 25 subjects affected by essential tremor and analysed by a Berg-Fourier frequency analyser before and during venous infusion of the following drugs: propranolol (beta-blocker), clonidine (alpha-presynaptic adrenergic agonist), urapidil (alpha-postsynaptic blocker), trazodone (adrenolytic agent) and placebo. The washout interval between infusions was 3 days. Recordings and data analyses were performed in a double-blind crossover trial. Tremor was classified as: at rest; postural (arms hyperextended); and intention (finger-nose test). Analysis of the results showed that propranolol and clonidine reduced significantly (P = 0.01 and P = 0.009, respectively) the power spectrum of postural tremor, but left at rest and intention tremors unchanged. No significant effects on the tremor power spectrum were observed after placebo, urapidil or trazodone administration. None of the drugs had any effect on tremor frequency.
Caccia
M R
MR
Neurological Clinic, L. Sacco Hospital, Milan, Italy.
Osio
M
M
Galimberti
V
V
Cataldi
G
G
Mangoni
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003000:Clonidine / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D014196:Trazodone / Q000627:therapeutic use*; D014202:Tremor / Q000188:drug therapy* / Q000503:physiopathology
D010879:Piperazines; D011433:Propranolol; C015568:urapidil; D003000:Clonidine; D014196:Trazodone